azimilide dihydrochloride

Known as: 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-2,4-imidazolidinedione dihydrochloride, 2,4-Imidazolidinedione, 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-, dihydrochloride, Azimilide Hydrochloride 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2008
024619962008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
OBJECTIVES The purpose of this study was to assess the incidence, temporal characteristics, and risk factors associated with… (More)
  • figure 1
  • table 4
  • table 2
Is this relevant?
2006
2006
Azimilide hydrochloride (azimilide), an investigational antiarrhythmic drug, has shown variable efficacy in preventing atrial… (More)
Is this relevant?
2005
2005
Azimilide dihydrochloride is an antiarrhythmic drug with Vaughn Williams class III properties, which blocks both fast (IKr) and… (More)
Is this relevant?
2004
2004
OBJECTIVES This study evaluated the effects of azimilide dihydrochloride (AZ) on anti-tachycardia pacing (ATP) and shock… (More)
Is this relevant?
2004
2004
OBJECTIVES The purpose of this study was to assess the effect of oral azimilide dihydrochloride (AZ) 100 mg versus placebo on the… (More)
Is this relevant?
2002
2002
BACKGROUND Many class III antiarrhythmic agents lose efficacy under beta-adrenergic stimulation and at high heart rates (reverse… (More)
Is this relevant?
Review
2000
Review
2000
Azimilide dihydrochloride (Stedicor) is a new class III anti-arrhythmic agent that is being developed by Proctor & Gamble to… (More)
Is this relevant?
1999
1999
Azimilide pharmacokinetics and pharmacodynamics were characterized in a safety and tolerance study of intravenously administered… (More)
Is this relevant?
Review
1998
Review
1998
Azimilide, a novel class III antiarrhythmic agent, blocks both the slowly activating (IKs) and rapidly activating (IKr… (More)
Is this relevant?
1996
1996
INTRODUCTION The effects of a Class III agent, azimilide dihydrochloride, on atrial flutter circuits were studies in a functional… (More)
Is this relevant?